ColetteNgoziOwensMD
Oncology • Middletown, NJHematologic Oncology
Assistant Attending at Memorial Sloan Kettering Cancer Center
Overview of Dr. Owens
Dr. Colette Owens is an oncologist in Middletown, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Hackensack Meridian Health Riverview Medical Center, and Memorial Sloan Kettering Monmouth. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 7 years. She is one of 494 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at Hackensack Meridian Health Riverview Medical Center who specialize in Oncology. She has more than 20 publications and over 500 citings.
Office
480 Red Hill Road
Middletown, NJ 07748
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Rutgers Robert Wood Johnson Medical SchoolClass of 2010
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2016 - 2025
NY State Medical License 2012 - 2025
Publications & Presentations
PubMed
- 91 citationsFollicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroupsConnie Lee Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith
Blood Cancer Journal. 2020-07-17 - 2 citationsCabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2024-08-01 - 86 citationsPhase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2021-06-25
Abstracts/Posters
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaColette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Colette Owens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Challenges of Managing Older Patients with Diffuse Large B-cell LymphomaSeptember 10th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
